Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
The enterprise value (EV) is $2.79B.
ENTERPRISE VALUE (EV)
$2.79B
Precigen, Inc.
Market Cap
$2.73B
Enterprise Value (EV)
$2.79B
| NAME | MARKET CAP | ENTERPRISE VALUE (EV) |
|---|---|---|
| Precigen, Inc. (PGEN) | $2.73B | $2.79B |
| Acadia Healthcare Company, Inc. (ACHC)vs › | $2.69B | $5.08B |
| MBX Biosciences, Inc. Common Stock (MBX)vs › | $2.68B | $2.63B |
| Aveanna Healthcare Holdings Inc. (AVAH)vs › | $2.68B | $4.09B |
| AtriCure, Inc. (ATRC)vs › | $2.79B | $2.69B |
| Neogen Corporation (NEOG)vs › | $2.64B | $3.25B |
| TransMedics Group, Inc. (TMDX)vs › | $2.81B | $3.20B |
| Dyne Therapeutics, Inc. (DYN)vs › | $2.84B | $2.18B |
| NewAmsterdam Pharma Company N.V. (NAMS)vs › | $2.59B | $2.16B |
| Privia Health Group, Inc. (PRVA)vs › | $2.58B | N/A |
Market Cap
$2.73B
Total Debt
$93.17M
Cash
$30.23M
Enterprise Value
$2.79B
Why use EV instead of Market Cap?
Enterprise Value represents the total value of a company as if you were to acquire it completely - paying for equity while assuming debt and receiving cash.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
